BioNTech SE (BVMF:B1NT34)
30.61
-0.43 (-1.39%)
At close: Nov 17, 2026
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of 121.69 billion as of November 18, 2026. Its market cap has decreased by 7.03% in one year.
Market Cap
121.69B
Enterprise Value
34.09B
Revenue
14.24B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from 12.31B to 121.69B, an increase of 888.41%. That is a compound annual growth rate of 38.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 121.69B | -3.49% |
| Dec 31, 2025 | 126.09B | -25.38% |
| Dec 31, 2024 | 168.96B | 38.79% |
| Dec 29, 2023 | 121.74B | -36.92% |
| Dec 30, 2022 | 192.99B | -44.37% |
| Dec 31, 2021 | 346.92B | 240.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 77.11B |
| Bradsaúde | 48.03B |
| Raia Drogasil | 24.43B |
| Hypera | 15.62B |
| Fleury | 11.29B |
| Diagnósticos da América | 4.20B |
| Blau Farmacêutica | 2.20B |
| Hospital Mater Dei | 1.74B |